Kidney cancer gene reveals an unexpected weakness and a new path for treatment. A common genetic mutation that helps some kidney cancers survive may also expose an unexpected weakness, one that MUSC Hollings Cancer Center researchers hope to transform into a new treatment strategy.
A apuração publicada por medicalxpress.com vira base para uma leitura editorial direta e contextualizada.
Trechos de apoio da pauta: A common genetic mutation that helps some kidney cancers survive may also expose an unexpected weakness, one that MUSC Hollings Cancer Center researchers hope to transform into a new treatment strategy. In a study published in Cancer Research, Aguirre de Cubas, Ph.D., and colleagues have discovered that kidney cancer cells lacking the tumor suppressor gene SETD2 become highly dependent on a protein called BCL-xL for survival.
- Ponto de atenção: kidney.
- Ponto de atenção: cancer.
- Ponto de atenção: gene.
Em resumo, a leitura editorial acompanha o impacto do tema no nicho Fitness.
:quality(85)/f5908607-405a-4c01-85c7-1d89ebcc1c87.jpg)
